Faculty profile
Jonathan Choy
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of British Columbia directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $803,250
Localized immuno-cloaking organ engineering approach to prevent transplant rejection without immunosuppressants
CIHR · 2022 · Co-investigator
- $918,000
Novel endothelial engineering and localized immunosuppression approaches for the protection of organ transplants
CIHR · 2020 · Principal investigator
- $10,000
Joint Meeting of the Canadian Cancer Immunotherapy Consortium and ImmunoBC 2018
CIHR · 2018 · Co-investigator
Localized immuno-cloaking organ engineering approach to prevent transplant rejection without immunosuppressants
Principal investigators: Kizhakkedathu, Jayachandran N
Keywords: Immune-Cloaking; Immune-Mediated Rejection; Immunoengineering; Immunosupressing Polymers; Kidney Transplantation; Localized Immunotherapy; Lung Transplantation; Organ Engineering; Organ Protection; Transplantation
Novel endothelial engineering and localized immunosuppression approaches for the protection of organ transplants
Principal investigators: Kizhakkedathu, Jayachandran N; Choy, Jonathan C
Keywords: Acute And Chronic Rejection; Artery Transplantation; Biocompatible Glycopolymers; Biomaterials And Bioactive Polymers; Cell Surface Engineering; Enzymatic Cell Surface Modification; Immune-Mediated Rejection; Immunomodulation; Kindeny Transplantion; Localized Immune Therapy
Joint Meeting of the Canadian Cancer Immunotherapy Consortium and ImmunoBC 2018
Principal investigators: Nelson, Brad H
Keywords: Cancer Immunotherapy; Cell Therapy; Immune Modulation; Immunotherapy; Knowledge Transfer; Mentorship; National Meeting; Vaccination
Liposomal nanoparticle formulations of difficult to formulate drugs
Principal investigators: Cullis, Pieter R
Keywords: Anticancer Drugs; Cancer Chemotherapy; Drug Delivery; Immunosuppressive Drugs; Liposomes; Membrane Antigen Targeting; Prodrug
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.